Product Information
PARICALCITOL 2 MCG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $2.5886 per EA under NDC 65862093730. Its NADAC has been published 145 times since Mar 29, 2017.
FDA first approved this application on Jan 14, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 ug/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862093730
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PARICALCITOLApproval Type
Generic (ANDA)
FDA Application
ANDA207672FDA Approved
1/14/2016
TE Code
AB
On Market Since
1/14/2016
Pharmacological Classes
Price Statistics
The NADAC for PARICALCITOL 2 MCG CAPSULE has been published 145 times since Mar 29, 2017, and over the history we have for it it has declined 80.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5886 per EA |
|---|---|
| All-time high | $12.9667 (Aug 16, 2017) |
| All-time low | $1.7560 (Jan 21, 2026) |
| 52-week high | $2.6484 |
| 52-week low | $1.7560 |
| Median price | $7.5147 |
| Average price | $5.5676 |
| Largest weekly change | -76.5% (May 21, 2025) |
| Weeks tracked | 145 |
| Tracking since | Mar 29, 2017 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Paricalcitol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Vitamin D Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PARICALCITOL 2 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PARICALCITOL 2 MCG CAPSULE, manufactured by Aurobindo Pharma Limited, is $2.5886 per EA (NDC 65862093730), effective Sep 30, 2026.
How has the price of PARICALCITOL 2 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for PARICALCITOL 2 MCG CAPSULE has declined 80.0%. It has been tracked across 145 weekly CMS publications since Mar 29, 2017.
What are the highest and lowest recorded NADAC prices for PARICALCITOL 2 MCG CAPSULE?
Since Mar 29, 2017, the NADAC for PARICALCITOL 2 MCG CAPSULE has ranged from a low of $1.7560 (Jan 21, 2026) to a high of $12.9667 (Aug 16, 2017), with a median of $7.5147 per EA.
Are there cheaper alternatives to PARICALCITOL 2 MCG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PARICALCITOL 2 MCG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures PARICALCITOL 2 MCG CAPSULE?
PARICALCITOL 2 MCG CAPSULE (NDC 65862093730) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.